Viewing Study NCT02338232


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2026-03-30 @ 12:40 PM
Study NCT ID: NCT02338232
Status: TERMINATED
Last Update Posted: 2024-05-01
First Post: 2015-01-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor:
Organization: